Press Announcement
World’s first at-home blood analyser for cancer transforms oncology care – delivering against the new NHS 10 Year Health Plan
With NHS capacity unable to meet the ever increasing number of patients receiving cancer treatment, there is major demand for new innovations that can streamline patient care. Accelerating care delivery in the home is a viable means to achieve this and is at the forefront of the 10 Year Health Plan.
Entia has released a new short film revealing how Liberty, the world’s first at-home blood analyser for cancer, is helping NHS patients avoid routine hospital trips, reclaim valuable time, and feel more in control of their care.
Deployed at Shrewsbury and Telford Hospital NHS Trust, the technology enables patients to check their blood levels from home using a simple finger prick, with results monitored remotely by NHS teams. The video captures the experience of both patient and clinician, highlighting the personal and NHS-wide impact of remote monitoring.
Watch the video:
Implications of innovation for the NHS
The video also serves as a call to action for other NHS trusts, demonstrating how technology like Liberty can be successfully embedded into day-to-day cancer care. As pressures on NHS services grow, innovation is no longer a luxury but a necessity.
“Our main challenges are related to capacity,” explains Dr Laura Pettit, a clinician at Shrewsbury and Telford NHS Trust. “We have more and more patients diagnosed with cancer, more patients living longer, and more treatment options available. But we haven't had the same increase in workforce to manage this growing demand.”
Liberty, she says, offers a solution to one of the most time-consuming aspects of treatment: routine blood monitoring. “Most cancer treatments require quite intense monitoring, particularly when a patient starts a new line of therapy. Having a device that can be used at home is very appealing. It stops the time burden for patients having to visit their phlebotomist, GP, or hospital.”
Liberty improves the patient experience
Sally, a patient with breast cancer, describes how Liberty has made a meaningful difference to her day-to-day life.
“I didn’t realise that blood tests would be such an important part of my treatment.” she recalls. “Just going to hospital is an upheaval…this machine has just made things so easy. I’m loving using it as home as it’s a two minute event. I take my own blood and it’s being monitored by the nurse remotely.”
Many patients such as Sally have to regularly attend hospital for routine blood tests, sometimes as often as weekly. So the opportunity to test from home can be both a huge relief and also provide additional reassurance.
Sally added: “It improves your quality of life, because it means that you have so much more time to do the things you want to do instead of having to concentrate on your illness.”
“I think this technology is very exciting. It’s a privilege to be involved in such innovation. This is the kind of solution the NHS should embrace to help address capacity challenges and improve patient care.
”
Importantly, Liberty also helps to reduce external barriers to care. “Patients in rural areas may find it more difficult to access services, especially when public transport is limited, parking is difficult, or fuel costs are high. These factors, while external to cancer itself, can impact a patient's mental wellbeing and treatment journey.”
By enabling home-based testing, Liberty provides patients with greater flexibility and emotional relief. “We believe this is empowering,” Dr Pettit adds. “It allows patients to schedule their day more freely and manage other commitments alongside their care.”
From a clinical standpoint, the benefits are just as clear. “Liberty has reduced the burden on GP surgeries, phlebotomy services, district nurses, and hospital blood test clinics. We're pleased to offer patients an alternative to standard venous blood draws, providing them with more convenience and autonomy at home.”
Dr Pettit concludes: “I think this technology is very exciting. It’s a privilege to be involved in such innovation. This is the kind of solution the NHS should embrace to help address capacity challenges and improve patient care.”
What’s next for Liberty?
Our work-to-date has set a precedent for how NHS Trusts can leverage innovative remote monitoring solutions to deliver more proactive and personalised care, even in the most remote parts of the UK. It also shows how at-home blood monitoring can offer cancer patients greater comfort, confidence and control during some of the most difficult moments of their lives.
As more NHS trusts look to modernise care pathways, Liberty offers a blueprint for how innovation can be implemented in real-world settings to deliver meaningful impact. We look forward to working closely with more NHS Trusts to ensure that as many patients as possible gain access to this life-changing innovations.